Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Ping Fan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1167-5858; OpenAlex author ID A5084033038. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: 3 papers · 2019: 5 papers · 2020: 2 papers · 2021: 1 paper

Papers 15

  1. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer. Co-author DOI 10.1038/s41419-021-04118-4↗
  2. GNG12 regulates PD-L1 expression by activating NF-κB signaling in pancreatic ductal adenocarcinoma. Last author DOI 10.1002/2211-5463.12784↗
  3. FBP1 binds to the bromodomain of BRD4 to inhibit pancreatic cancer progression. Co-author PMID 32195024↗
  4. B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biocel.2019.01.011↗
  5. HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer. Co-author DOI 10.1016/j.pan.2019.01.011↗
  6. Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer. Co-author DOI 10.1186/s13046-019-1044-z↗
  7. PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer. Co-author DOI 10.1186/s13046-019-1466-7↗
  8. USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1. Co-author PMID 31497353↗
  9. Far upstream element-binding protein 1 is up-regulated in pancreatic cancer and modulates immune response by increasing programmed death ligand 1. Co-author DOI 10.1016/j.bbrc.2018.10.009↗
  10. FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma. First author DOI 10.1186/s13046-018-0888-y↗
  11. 3F-Box protein 32 degrades ataxia telangiectasia and Rad3-related and regulates DNA damage response induced by gemcitabine in pancreatic cancer. First author DOI 10.3892/ol.2018.8367↗
  12. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion. Co-author DOI 10.1074/jbc.m116.764407↗
  13. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway. Co-author DOI 10.1186/s12943-017-0627-6↗
  14. Overexpression of membrane-type 2 matrix metalloproteinase induced by hypoxia-inducible factor-1α in pancreatic cancer: Implications for tumor progression and … Co-author DOI 10.3892/mco.2014.357↗
  15. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions. Co-author DOI 10.1016/j.pan.2012.02.015↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xin Jin · 13 shared papers, 2017–2021 · strength 1.35
  2. Heshui Wu · 9 shared papers, 2012–2021 · strength 0.74
  3. Chong Yang · 5 shared papers, 2017–2020 · strength 0.49
  4. Jingyuan Zhao · 4 shared papers, 2018–2020 · strength 0.42
  5. Shikai Zhu · 4 shared papers, 2014–2020 · strength 0.36
  6. Zibo Meng · 3 shared papers, 2019–2020 · strength 0.32
  7. Tao Liu · 3 shared papers, 2017–2019 · strength 0.24
  8. Bo Wang · 2 shared papers, 2018–2019 · strength 0.19
  9. Yan Ping Sun · 1 shared paper, 2021 · strength 0.14
  10. Jian Shen · 1 shared paper, 2021 · strength 0.14
  11. Yingke Zhou · 1 shared paper, 2021 · strength 0.14
  12. Yang Gao · 1 shared paper, 2021 · strength 0.14
  13. Dianyun Ren · 1 shared paper, 2021 · strength 0.14
  14. Kun Zhang · 1 shared paper, 2020 · strength 0.12
  15. Juan Li · 1 shared paper, 2020 · strength 0.11
  16. Rui Fang · 1 shared paper, 2019 · strength 0.11
  17. Guo‐fu Hu · 1 shared paper, 2019 · strength 0.11
  18. Zhiqiang Liu · 1 shared paper, 2019 · strength 0.09
  19. Shihong Wu · 1 shared paper, 2019 · strength 0.09
  20. Han-Qing Wu · 2 shared papers, 2012–2014 · strength 0.07
  21. Tao Yin · 1 shared paper, 2017 · strength 0.06
  22. Wei Zhou · 1 shared paper, 2017 · strength 0.06
  23. Shanmiao Gou · 1 shared paper, 2017 · strength 0.06
  24. Li Wang · 1 shared paper, 2017 · strength 0.06
  25. Bo Wang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.